The Clinton Health Access Initiative, Inc. (CHAI) is a global health organization committed to our mission of saving lives and reducing the burden of disease in low-and middle-income countries. We work at the invitation of governments to support them and the private sector to create and sustain high-quality health systems.
CHAI was founded in 2002 in response to the HIV/AIDS epidemic with the goal of dramatically reducing the price of life-saving drugs and increasing access to these medicines in the countries with the highest burden of the disease. Over the following two decades, CHAI has expanded its focus. Today, along with HIV, we work in conjunction with our partners to prevent and treat infectious diseases such as COVID-19, malaria, tuberculosis, and hepatitis. Our work has also expanded into cancer, diabetes, hypertension, and other non-communicable diseases, and we work to accelerate the rollout of lifesaving vaccines, reduce maternal and child mortality, combat chronic malnutrition, and increase access to assistive technology. We are investing in horizontal approaches to strengthen health systems through programs in human resources for health, digital health, and health financing. With each new and innovative program, our strategy is grounded in maximizing sustainable impact at scale, ensuring that governments lead the solutions, that programs are designed to scale nationally, and learnings are shared globally.
At CHAI, our people are our greatest asset, and none of this work would be possible without their talent, time, dedication and passion for our mission and values. We are a highly diverse team of enthusiastic individuals across 40 countries with a broad range of skillsets and life experiences. CHAI is deeply grounded in the countries we work in, with majority of our staff based in program countries.
In India, CHAI works in partnership with its India registered affiliate William J Clinton Foundation (WJCF) under the guidance of the Ministry of Health and Family Welfare (MoHFW) at the Central and States' levels on an array of high priority initiatives aimed at improving health outcomes. Currently, WJCF supports government partners across projects to expand access to quality care and treatment for HIV/AIDS, Hepatitis, tuberculosis, COVID-19, common cancers, sexual and reproductive health, immunization, and essential medicines.
Learn more about our exciting work: http://www.clintonhealthaccess.org
Program Overview
With an estimated annual mortality of ~911,800 and an incidence of more than 1.4 million new cases in 2022 (source: Globocan), cancer has rapidly grown into one of the leading drivers of mortality and morbidity in India. Cervical cancer, with an annual mortality of ~79,000 and an incidence of ~127,500 (source: Globocan, 2022), is the second most common cancer among women in India. Approximately 90% of cervical cancer cases are detected at a late (stage III and above), leading to a high Mortality Incidence Ratio (MIR of more than 60%). The five-year survival rate for early-stage cervical cancer is 73.2%, whereas the prognosis for advanced stage is poor, with five-year survival rate at 7.9%. Low awareness, limited availability of trained human resources and technology for treatment, broken referral systems and inadequate monitoring are key barriers in access to quality cancer care.
WJCF has initiated a program on secondary prevention of cervical cancer through improving access to screening and pre-cancer treatment services. The program will be implemented in the state of Rajasthan, where WJCF will support the state government:
Position summary:
WJCF is seeking a highly motivated, results-oriented individual with strong quantitative and analytical skills to support development of program strategy and implementation of program activities on secondary prevention of cervical cancer in Rajasthan. Candidates must have excellent problem-solving ability, good communication skills, be able to function independently, and have a strong commitment to excellence. The Analyst will be based in Jaipur, Rajasthan, India.
Last Date to Apply: 18th July, 2025
Software Powered by iCIMS
www.icims.com